SONA — Sona Nanotech Share Price
0.000.00%
Last trade - 00:00- CA$41.15m
- CA$41.54m
- 19
- 12
- 84
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 33.58 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -168.35% | ||
| Return on Equity | -1519.19% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Oct | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.
Directors
- Daniel Whittaker NEC
- Darren Rowles PRE (40)
- David Regan CEO (51)
- Robert Randall CFO
- James Megann DRC
- Michael Gross IND
- John Lievonen IND
- Robert McKay IND
- Last Annual
- October 31st, 2023
- Last Interim
- January 31st, 2024
- Incorporated
- August 8th, 2018
- Public Since
- October 4th, 2018
- No. of Employees
- 8
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 99,145,361
- Address
- Purdy's Wharf Tower 2, HALIFAX, B3J 3R7
- Web
- https://www.sonanano.com/
- Phone
- +1 9024420653
- Auditors
- Manning Elliott LLP
Upcoming Events for SONA
Sona Nanotech Inc Annual Shareholders Meeting
Similar to SONA
Aquarius Surgical Technologies
Canadian Securities Exchange
Cannabix Technologies
Canadian Securities Exchange
Cognetivity Neurosciences
Canadian Securities Exchange
Gemina Laboratories
Canadian Securities Exchange
Izotropic
Canadian Securities Exchange
FAQ
What is the Sona Nanotech share price?
As of Today at 19:20 UTC, shares in Sona Nanotech are trading at CA$0.42. This share price information is delayed by 15 minutes.
How has the Sona Nanotech share price performed this year?
Shares in Sona Nanotech last closed at CA$0.42 and the price had moved by +159.38% over the past 365 days. In terms of relative price strength the Sona Nanotech share price has outperformed the Toronto Stock Exchange 300 Composite Index by +143.74% over the past year.
What are the analyst and broker recommendations for Sona Nanotech?
The overall consensus recommendation for Sona Nanotech is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Sona Nanotech dividend yield?
Sona Nanotech does not currently pay a dividend.
Does Sona Nanotech pay a dividend?
Sona Nanotech does not currently pay a dividend.
When does Sona Nanotech next pay dividends?
Sona Nanotech does not currently pay a dividend.
How do I buy Sona Nanotech shares?
To buy shares in Sona Nanotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sona Nanotech?
As of the previous close price of CA$0.42, shares in Sona Nanotech had a market capitalisation of CA$41.15m.
Where are Sona Nanotech shares listed?
Here are the trading details for Sona Nanotech:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: SONA
What kind of share is Sona Nanotech?
Based on an overall assessment of its quality, value and momentum Sona Nanotech is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sona Nanotech share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Sona Nanotech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sona Nanotech. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +106.56%.
As of the last closing price of CA$0.42, shares in Sona Nanotech were trading +59.57% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sona Nanotech PE Ratio?
The Sona Nanotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.42.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sona Nanotech?
Sona Nanotech's management team is headed by:
- Daniel Whittaker - NEC
- Darren Rowles - PRE
- David Regan - CEO
- Robert Randall - CFO
- James Megann - DRC
- Michael Gross - IND
- John Lievonen - IND
- Robert McKay - IND